PharmaMar instructs Linklaters on sale of Spanish and Italian subsidiaries
Linklaters advised PharmaMar on the sale of its Spanish subsidiary Zelnova Zeltia, and its Italian subsidiary Copyr, to Allentia Invest and Safoles.
The deal was valued at €33.4 million.
Zelnova Zeltia produces cleaning and disinfecting products for households and the hotel industry.
Copyr’s business lines include hygiene products for the agricultural industry.
The Linklaters team included Carmen Burgos (pictured), María Nussbaum and Pablo Medina.